Skip to main content
. 2015 Jun 12;10(6):e0129991. doi: 10.1371/journal.pone.0129991

Fig 3. Subgroup-analysis on the VAS Scores of the Diabetic and Non-diabetic Patients.

Fig 3

Subgroup-analysis was performed by subdividing RCTs according to whether the peripheral neuropathy diagnosed in patients was diabetic or non-diabetic. Taking ALC decreased VAS scores significantly in diabetic patients. VAS = Visual Analogue Scale; ALC = acetyl-l-carnitine; UCE = U.S.-Canadian-European Study; UC = U.S.-Canadian Study; SD = standard deviation; CI = confidence interval.